Company Filing History:
2 out of 159 
2 out of 517 
Years Active: 2022
Title: An Vandebosch: Innovator in Coronavirus Vaccine Development
Introduction
An Vandebosch is a notable inventor based in Herentals, Belgium. He has made significant contributions to the field of immunology, particularly in the development of vaccines for coronavirus infections. With a total of two patents to his name, Vandebosch's work is crucial in the ongoing fight against viral diseases.
Latest Patents
Vandebosch's latest patents focus on compositions and methods for preventing and treating coronavirus infections, specifically targeting SARS-CoV-2. These inventions include immunogenic compositions and vaccines that contain proteins or polynucleotides encoding the coronavirus. The patents also outline methods for treating and preventing infections by administering these vaccines to subjects, such as humans. Additionally, they provide techniques for detecting and monitoring protective antibody responses against the virus.
Career Highlights
Throughout his career, An Vandebosch has worked with prominent organizations, including Janssen Pharmaceuticals and Beth Israel Deaconess Medical Center. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Vandebosch's notable coworkers include Johannes Petrus Maria Langedijk and Lucy Rutten, who have also played significant roles in advancing vaccine research and development.
Conclusion
An Vandebosch's innovative work in the field of coronavirus vaccines highlights his commitment to improving public health through scientific research. His contributions are vital in the ongoing efforts to combat viral infections and protect communities worldwide.